Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant
This study is ongoing, but not recruiting participants.
Study NCT00005113   Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received: April 14, 2000   Last Updated: September 26, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
End-Stage Renal Disease
Kidney Transplantation
Additional conditions recognized in this trial
Kidney Diseases
Kidney Failure, Chronic
More general conditions related to this trial
Kidney Failure
Renal Insufficiency
Renal Insufficiency, Chronic
Urologic Diseases
Interventions listed in this trial
Cyclosporine
Sirolimus
Tacrolimus
Additional drug interventions recognized in this trial
Cyclosporins
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antineoplastic
Antifungal Agents
Antineoplastic Agents
Antirheumatic Agents
Dermatologic Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services